← FTC press releases
FTC Requires Baxter International and Claris Lifesciences to Divest 2 Types of Pharmaceutical Products as Condition of Baxter Acquiring Injectable Drugs Business from Claris
other
· 2017-07-01
Source
Authoritative
FTC press release
Machine
JSON-LD
·
Markdown